Trump Administration Unveils Plan to Broaden Access to GLP-1 Medications
President Trump has announced a new initiative aimed at increasing the availability of GLP-1 medications. The plan focuses on developing transdermal patches as an alternative delivery method and seeks to streamline FDA approval processes for these patches. Additionally, the administration proposes negotiating lower prices with drug manufacturers.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.